CClinicalTrials.gg
CompletedNCT02851160chemotherapyUpdated Aug 1, 2016

Perceptions and Representations of Cancer Chemotherapy

An observational study in Lung Cancer, sponsored by University Hospital, Montpellier. Completed. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2016-08-01.

Sponsored by University Hospital, Montpellier · Observational

Study type
Observational
Time perspective
Retrospective
Enrollment
75
Ages
18 Years to 100 Years
Sex
All
01

Study summary

Qualitative study on data from interviews such patients, relatives and doctors involved in the implementation of cancer care. Framework type of method using grounded theory

Read the detailed description

The word chemotherapy itself, because it belongs to the secular knowledge and therefore Doxa is a hard word, which stores what it is stable, common and therefore impersonal. It has the properties of a symbol, that is to say that joint several meanings, some of which are contradictory.

The objective of the research:

To determine the perceptions and representations of chemotherapy, its physical impacts, psychological and relational.

To qualitatively compare the performances of chemotherapy as it has an end as scheduled for adjuvant chemotherapy, or endless precise as in the palliative chemotherapy

02

Conditions studied

  • Lung Cancer
03

In context

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

  • 30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment
  • 30 significant others (relatives) major applicant lung cancer patients chemotherapy either palliation or as adjuvant to surgery
  • 15 Doctors oncologists performing either chemotherapy as palliative or adjuvant as surgical treatment

Inclusion criteria

  • 30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment
  • 30 significant others (relatives) major applicant lung cancer patients chemotherapy either palliation or as adjuvant to surgery
  • 15 Doctors oncologists performing either chemotherapy as palliative or adjuvant as surgical treatment

Exclusion criteria

Exclusion Criteria:

  • NA
05

Study design

Time perspective
Retrospective
Enrollment
75 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients requiring lung cancer chemotherapy

    30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment having a semi-structured interview conducted by a clinical psychologist

    Other: semi-structured interview conducted by a clinical psychologist

  • Family of lung cancer patients receiving chemotherapy

    30 Family of lung cancer patients receiving chemotherapy having a semi-structured interview conducted by a clinical psychologist

    Other: semi-structured interview conducted by a clinical psychologist

  • doctors caring for lung cancer patients receiving chemotherapy

    15 doctors caring for lung cancer patients receiving chemotherapy 15 have a semi-structured interview conducted by a psychiatrist specialized in psycho-oncology

    Other: semi-structured interview conducted by a psychiatrist specialized in psycho-oncology

Interventions

  • Othersemi-structured interview conducted by a clinical psychologist

    semi-structured interview conducted by a clinical psychologist

  • Othersemi-structured interview conducted by a psychiatrist specialized in psycho-oncology

    semi-structured interview conducted by a psychiatrist specialized in psycho-oncology

06

What researchers measure

Primary outcomes

  1. The semi-structured interview

    The interview will be analyzed in a framework type of method (grounded theory) in accordance with the guidelines coreq.

    Time frame: 1 day (day of inclusion)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 1, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02851160
Lead sponsor
University Hospital, Montpellier
Responsible party
Sponsor
First posted
Aug 1, 2016
Start date
Mar 2015
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Aug 1, 2016

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion